Aji Bio-Pharma Press Releases Press Releases June 30, 2020 Ajinomoto Bio-Pharma Services Introduces AJILITY Fast Track Platform for Drug Product Manufacturing Read more June 2, 2020 Ajinomoto Bio-Pharma Services Completes Acquisition of Granules OmniChem Joint Venture in India Read more May 27, 2020 Ajinomoto Bio-Pharma Services Signs Manufacturing Agreement with Humanigen for Lenzilumab, Currently in FDA-Approved Phase III Study for COVID-19 Read more May 5, 2020 Ajinomoto Bio-Pharma Services Announces Manufacturing Partnership with CytoDyn for Drug Product Used in COVID-19 Clinical Trials Read more April 30, 2020 Trio Pharmaceuticals, Inc. and Ajinomoto Bio-Pharma Services Enter into a Development Collaboration for a Novel Antibody Therapeutic Read more March 10, 2020 Ajinomoto Bio-Pharma Services Announces Formation of External Advisory Board Read more September 2, 2019 Information accompanying the revision of the consumption tax rate Read more August 29, 2019 Ajinomoto Bio-Pharma Services Acquires Remaining Interest in Granules OmniChem Joint Venture in India Read more April 9, 2019 Information on Service Brand Name Change Read more April 9, 2019 GeneDesign Joins Ajinomoto Bio-Pharma Services and Opens Oligonucleotide API Development Center Read more April 3, 2019 Jean-Baptiste Agnus Joins Ajinomoto Bio-Pharma Services’ Global Leadership Team as Vice President of Sales and Marketing Read more March 12, 2019 Ajinomoto Bio-Pharma Services Announces Capital Expansion to Fuel Growth Read more Loading…Load More
